ARCT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arcturus Therapeutics Holdings Inc

Watchlist Manager

Watchlist

Price: 15.57 USD -1.58% Market Closed

Market Cap: $442.5m

	Arcturus Therapeutics Holdings Inc NASDAQ:ARCT	US
	AC Immune SA NASDAQ:ACIU	CH
C	Chememan PCL SET:CMAN	TH
	National Australia Bank Ltd ASX:NAB	AU

Profitability Summary

Arcturus Therapeutics Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-348%

Negative 3Y Average Operating Margin

-91%

Declining Operating Margin

17% > -348%

Negative Net Margin

-318%

Negative 3Y Average Net Margin

-76%

Declining Net Margin

30% > -318%

Negative Free Cash Flow Margin

-248%

Negative 3Y Average Free Cash Flow Margin

-59%

Declining Free Cash Flow Margin

48% > -248%

Negative ROE

-46%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-80%

Declining ROIC

61% > -157%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.